The largest database of trusted experimental protocols

Alk d5f3 antibody

Manufactured by Cell Signaling Technology
Sourced in United States

The ALK (D5F3) antibody is a primary antibody that specifically recognizes the Anaplastic Lymphoma Kinase (ALK) protein. It is a mouse monoclonal antibody that can be used for the detection of ALK expression in various biological samples, such as cell lysates or tissue sections, through techniques like Western blotting or immunohistochemistry.

Automatically generated - may contain errors

4 protocols using alk d5f3 antibody

1

Analyzing ALK phosphorylation in PC12 and neuroblastoma cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Electroporated PC12 cells seeded in six-well plates as described above were cultured in RPMI 1640 medium supplemented with 7% horse serum and 3% FBS for 24 h and then starved for 36 h. Both PC12 cells and human neuroblastoma cells were lysed directly in 1× SDS sample buffer. Precleared lysates were run on SDS/PAGE. DrLtk or HsALK phosphorylation was analyzed with pALK-Y1278 antibodies (Cell Signaling Technology) and activation of downstream components was detected with pERK1/2 antibodies (Cell Signaling Technology). Pan-ERK (BD Biosciences) was employed as loading control. Total Ltk was detected with anti-Myc tag antibody (ab9132; Abcam). Total ALK was detected with ALK (D5F3) antibody (Cell Signaling Technology). ALKALs were detected with anti-HA.11 antibodies (Clone 16B12; BioLegend).
+ Open protocol
+ Expand
2

Drosophila Genetic Manipulation Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard Drosophila husbandry procedures were followed. Stocks were maintained on a potato-mash based diet at room temperature. Crosses were performed at 25°C and 60% humidity level. The UAS-ALK-L1198F and UAS-ALK-G1201E constructs were generated using standard cloning techniques and transgenic flies were obtained by injection (BestGene Inc.). white1118 (w1118) flies were used as control; GMR-Gal4 (#1104) was received from the Bloomington Drosophila Stock Center at Indiana University (BDSC; NIH P40OD018537). UAS-ALK, UAS-ALK-F1174L, UAS-ALK-I1250T as well as UAS-FAM150A (AUG-β) and UAS-FAM150B (AUG-α) were used for ectopic expression studies in the developing Drosophila eye employing the GAL4-UAS system. Staining of imaginal discs was described previously [38 (link)]. The rabbit monoclonal ALK (D5F3) antibody was purchased from Cell Signalling and employed at a 1:200 dilution. The hybridoma, monoclonal mouse antibody 4F3 (anti-discs large; employed at 1:500), deposited by Corey Goodman was obtained from the Developmental Studies Hybridoma Bank (DSHB), created by the NICHD of the NIH and maintained at The University of Iowa. Samples were analysed under Zeiss Axio Imager.Z2 and AxioZoom.V16 microscopes. Images were acquired with a Zeiss LSM800 confocal microscope or with an Axiocam 503 colour camera employing ZEN blue edition software.
+ Open protocol
+ Expand
3

Immunohistochemical Staining of ALK, E-cadherin, and Vimentin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Routine immunohistochemical staining for ALK in xenograft tumors and LoVo spheroids was performed on a Benchmark-Ultra automated system (Ventana-Roche, Tucson, USA) using pre-diluted antibodies. All specimens have been formalin-fixed and paraffin-embedded (FFPE). The following antibodies were used: ALK D5F3 antibody (Cell Signaling, Danvers, USA), E-cadherin clone 36 mAb (Ventana-Roche, Tucson, USA), Vimentin clone V6 mAb (Ventana-Roche, Tucson, USA). The OptiView DAB IHC Detection Kit was used for detection.
+ Open protocol
+ Expand
4

Comprehensive Molecular Profiling of Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CREATE trial included ALK-positive and ALK-negative patients, centrally assessed using both IHC and FISH as described previously in the study protocol. A tumor was deemed ALK-positive if it showed immunopositivity confirmed by IHC with an ALK1 antibody (DAKO) and/or FISH using the Vysis LSI ALK dual color breakapart rearrangement probe (Abbott Molecular), with at least 15% cells staining positive or showing the rearrangement. As part of the current, post hoc exploratory work, further IHC was performed for ALK, ROS1, and NTRK on tissue sections, using the ALK D5F3 antibody (Cell Signaling Technology), ROS1 D4D6 antibody (Cell Signaling Technology), and pan-TRK EPR17341 antibody (Abcam) with 1:50, 1:200 dilutions, and 28 mg/mL, respectively. The Envision Plus detection system (DAKO) was used as the secondary antibody. The anchored multiplex PCR-based targeted next-generation sequencing using the Archer FusionPlex CTL Panel (Archer) was applied to study the presence of gene fusions, including ALK/ROS1 in 24 tumors (15) , in which 20 had sufficient material and acceptable RNA quality.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!